Nepafenac
Overview
Nepafenac is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1021).
API suppliers (5)
Suppliers of Nepafenac evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 4 of 5 suppliers.
3 of 5 hold a GMP certificate on record in the EU or UK registers
- Carbogen Amcis AGSwitzerland1 active DMF GMP on record
- ALP PHARM BEIJING CO LTD1 active DMF
- MEDICHEM SASpain1 active DMF GMP on record
- MATRIX PHARMACORP PRIVATE LTDIndia1 active DMF
- FDC LimitedIndia1 active DMF GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (2 approved US products), the latest listed US patent on Nepafenac expires 31 Mar 2032. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 2-(2-amino-3-benzoylphenyl)acetamide
- Canonical SMILES
- C1=CC=C(C=C1)C(=O)C2=CC=CC(=C2N)CC(=O)N
- InChIKey
- QEFAQIPZVLVERP-UHFFFAOYSA-N
Do you supply Nepafenac? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.